EurekAlert!, a service of AAAS
Home About us
Advanced Search
18-Sep-2014 13:51
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Bioinformatics

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 426-450 out of 718.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>

Public Release: 26-Aug-2013
American Journal of Human Genetics
Researchers develop software tool for cancer genomics
Researchers at the Medical College of Wisconsin and the National Cancer Institute have developed a new bioinformatics software tool designed to more easily identify genetic mutations responsible for cancers.

Contact: Maureen Mack
mmack@mcw.edu
Medical College of Wisconsin

Public Release: 26-Aug-2013
PLOS ONE
Study offers insight into the origin of the genetic code, team reports
An analysis of enzymes that load amino acids onto transfer RNAs -- an operation at the heart of protein translation -- offers new insights into the evolutionary origins of the modern genetic code, researchers report. Their findings appear in the journal PLOS ONE.
National Science Foundation, U.S. Department of Agriculture

Contact: Diana Yates
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign

Public Release: 25-Aug-2013
Nature Methods
New tool enhances the search for genetic mutations
Reed Cartwright, a researcher at Arizona State University's Biodesign Institute, along with colleagues at ASU, Washington University and the Wellcome Trust Sanger Institute, Cambridge, UK, report on a new software tool known as DeNovoGear, which uses statistical probabilities to help identify mutations and more accurately pinpoint their source and their possible significance for health.

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University

Public Release: 25-Aug-2013
Nature Genetics
Scientists pinpoint 105 additional genetic errors that cause cystic fibrosis
Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis (CF), it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.
NIH/National Institute of Diabetes and Digestive and Kidney, Cystic Fibrosis Foundation Therapeutics, Cystic Fibrosis Foundation, Fundação para a Ciência e a Tecnologia

Contact: Catherine Kolf
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine

Public Release: 21-Aug-2013
Nature Biotechnology
Genome researchers at Bielefeld University decode the hamster genome
Genome researchers from Bielefeld University's Center for Biotechnology headed by Professor Dr. Alfred Pühler have succeeded in sequencing the genome of the Chinese hamster. The Chinese hamster supplies the cell cultures used by the pharmaceutical industry to produce biopharmaceutical products such as antibodies used in medicine. This costly project was only possible thanks to a cooperation between Bielefeld University and its international project partners. The researchers have now published their results in the internationally renowned scientific journal 'Nature Biotechnology'.

Contact: Dr. Alfred Pühler
puehler@cebitec.uni-bielefeld.de
49-052-110-68750
Bielefeld University

Public Release: 15-Aug-2013
Journal of Clinical Investigation
JCI early table of contents for Aug. 15, 2013
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Aug. 15, 2013, in the JCI: Biomarkers predict time to ovarian cancer recurrence, A molecule involved in development of chronic obstructive pulmonary disease, Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis and many more.

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 14-Aug-2013
Nature
Cancer's origins revealed
Scientists have provided the first comprehensive genomic map of mutational processes that drive tumour development. Together, these mutational processes explain the majority of mutations found in 30 of the most common cancer types.

Contact: Aileen Sheehy
press.office@sanger.ac.uk
44-012-234-92368
Wellcome Trust Sanger Institute

Public Release: 11-Aug-2013
Nature
NIH-funded study discovers new genes for childhood epilepsies
A genetic study of childhood epilepsies has linked two new genes to severe forms of disease and provides a novel strategy for identifying therapy targets. The results suggest this may be a highly effective way to find and confirm many disease-causing gene mutations.
NIH/National Institute of Neurological Disorders and Stroke, Finding a Cure for Epilepsy and Seizures, Richard Thalheimer Philanthropic Fund

Contact: Christopher Thomas
nindspressteam@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 8-Aug-2013
American Journal of Human Genetics
Genetic evidence shows recent population mixture in India
Researchers have found that modern-day India is the result of recent population mixture among divergent demographic groups.
National Institutes of Health, National Science Foundation, UKIERI Major Award, Network Project

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 6-Aug-2013
$20,000 Arizona Community Foundation grant helps fund TGen education
The Translational Genomics Research Institute (TGen) received another boost today for Science, Technology, Engineering and Math education with a $20,000 grant from the Arizona Community Foundation. TGen's Pathogen Genomics Division (TGen North) in Flagstaff secured the grant for the research institute's TGen2School program. At TGen North, some of the world's top experts study disease-causing microorganisms, including everything from valley fever to MRSA and even anthrax and plague.
Arizona Community Foundation

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 5-Aug-2013
Annals of Internal Medicine
NYU Langone researchers offer new model, helping clinicians prioritize recommended preventive
With physicians facing increasing demands on their time, it can be extremely difficult to prioritize which preventive care methods should be used for their patients. Now, two researchers at NYU Langone Medical Center have developed a mathematical model that will save time, lead to enhanced care, and potentially save lives.
New York University School of Medicine

Contact: Lorinda Klein
lorindaann.klein@nyumc.org
212-404-3533
NYU Langone Medical Center / New York University School of Medicine

Public Release: 4-Aug-2013
Nature Chemical Biology
Researchers dismantle bacteria's war machinery
This is a veritable mechanics of aggression on the nanoscale. Certain bacteria, including Staphylococcus aureus, have the ability to deploy tiny darts. This biological weapon kills the host cell by piercing the membrane. Researchers at EPFL have dismantled, piece by piece, this intriguing little machine. Published in Nature Chemical Biology, this discovery offers new insight into the fight against pathogens that are increasingly resistant to antibiotics.

Contact: Matteo Dal Peraro
matteo.dalperaro@epfl.ch
41-798-083-220
Ecole Polytechnique Fédérale de Lausanne

Public Release: 2-Aug-2013
Cell
Wired for change
A study of gene expression led by scientists at the EMBL-European Bioinformatics Institute and the University of Cambridge has revealed the first steps of evolution in gene regulation in mice. Published in the journal Cell, the research has implications for the study of differences in gene regulation between people.
European Research Council, Marie Curie Re-Integration Award, EMBO Young Investigator Programme

Contact: Sonia Furtado Neves
sonia.furtado@embl.de
European Molecular Biology Laboratory

Public Release: 1-Aug-2013
Cell
How 'junk DNA' can control cell development
Researchers from the Gene and Stem Cell Therapy Program at Sydney's Centenary Institute have confirmed that, far from being "junk," the 97 percent of human DNA that does not encode instructions for making proteins can play a significant role in controlling cell development. And in doing so, the researchers have unravelled a previously unknown mechanism for regulating the activity of genes, increasing our understanding of the way cells develop and opening the way to new possibilities for therapy.
Centenary Institute

Contact: Tamzin Byrne
tamzin@scienceinpublic.com.au
043-297-4400
Centenary Institute

Public Release: 1-Aug-2013
Cell
Targeted therapy identified for protein that protects and nourishes cancer
UT MD Anderson scientists identify the first targeted therapy to block Skp2, which suppresses a cellular defense against cancer and activates glycolysis to feed tumors. The drug restores the senescence program and stifles glycolysis to thwart tumor progression.
NIH/National Cancer Institute, American Cancer Society, Susan G. Komen for the Cure

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center

Public Release: 1-Aug-2013
Cell
New designer compound treats heart failure by targeting cell nucleus
Researchers from Case Western Reserve University School of Medicine and the Dana-Farber Cancer Institute have made a fundamental discovery relevant to the understanding and treatment of heart failure -- a leading cause of death worldwide. The team discovered a new molecular pathway responsible for causing heart failure and showed that a first-in-class prototype drug, JQ1, blocks this pathway to protect the heart from damage.
National Institutes of Health

Contact: Jessica Studeny
Jessica.studeny@case.edu
216-368-4692
Case Western Reserve University

Public Release: 31-Jul-2013
Stem Cells
Computational biology: Cells reprogrammed on the computer
Scientists at the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have developed a model that makes predictions from which differentiated cells -- for instance skin cells -- can be very efficiently changed into completely different cell types -- such as nerve cells, for example. This can be done entirely without stem cells. These computer-based instructions for reprogramming cells are of huge significance for regenerative medicine. The LCSB researchers present their results today in the prestigious scientific journal "Stem Cells".

Contact: Britta Schlüter
britta.schlueter@uni.lu
352-466-644-6563
University of Luxembourg

Public Release: 31-Jul-2013
Wonders of nature inspire exotic man-made materials
In this month's edition of Physics World, a group of physicists describe how unique structures in the natural world are inspiring scientists to develop new types of materials with unprecedented properties.

Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics

Public Release: 31-Jul-2013
Ecological Society of America 2013 Annual Meeting
Entomological Society of America announces 2013 fellows
The Entomological Society of America has elected ten new Fellows of the Society for 2013. The election as a Fellow acknowledges outstanding contributions to entomology in research, teaching, extension, or administration.

Contact: Richard Levine
rlevine@entsoc.org
301-731-4535
Entomological Society of America

Public Release: 31-Jul-2013
New England Journal of Medicine
ITN achieves scientific manuscript first -- provides open, interactive access to clinical trial data
Immune Tolerance Network researchers published data of their "Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (RAVE)" clinical trial using ITN TrialShare, a clinical trial data and analysis portal that provides open, unprecedented access to clinical trial data, analyses and specimens.

Contact: Philip Bernstein, Ph.D.
ITNCommunications@immunetolerance.org
240-235-6132
Immune Tolerance Network

Public Release: 29-Jul-2013
Chaos
Unraveling genetic networks
Now a special issue of the journal CHAOS, produced by AIP Publishing, explores new experimental and theoretical techniques for unraveling genetic networks.

Contact: Jason Socrates Bardi
jbardi@aip.org
240-535-4954
American Institute of Physics

Public Release: 26-Jul-2013
PhytoKeys
Database simplifies finding Canadian plant names and distribution
Determining the correct name of plants present in a particular area is often a chore to users of biodiversity information. VASCAN, the Database of Vascular plants of Canada, Saint Pierre and Miquelon, and Greenland, simplifies the task of finding such names, as well as the plant distribution at a regional level for all vascular plants established in the area covered.

Contact: Dr. Luc Brouillet
luc.brouillet@umontreal.ca
514-343-2142
Pensoft Publishers

Public Release: 25-Jul-2013
PLOS ONE
Microbial who-done-it for biofuels
A multi-institutional collaboration led by researchers with the Joint BioEnergy Institute and Joint Genome Institute has developed a promising technique for identifying microbial enzymes that can effectively deconstruct biomass into fuel sugars under refinery processing conditions.
US Department of Energy Office of Science

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory

Public Release: 23-Jul-2013
HudsonAlpha awarded grant to improve diagnoses of childhood genetic disorders
Even in the absence of a ready solution, knowing why a child faces physical, emotional and intellectual challenges is helpful to physicians and families. Researchers at the HudsonAlpha Institute for Biotechnology are using high throughput genomic sequencing to meet major diagnostic needs for childhood genetic disorders through a multi-year grant potentially totaling more than $7.6 million from the National Institutes of Health. The study grant is part of the NIH's Clinical Sequencing Exploratory Research program.
NIH/National Human Genome Research Institute Clinical Sequencing Exploratory Research

Contact: Holly Ralston
hralston@hudsonalpha.org
256-508-8954
HudsonAlpha Institute for Biotechnology

Public Release: 22-Jul-2013
Diabetes
Could turning on a gene prevent diabetes?
The resistance to insulin seen in type 2 diabetics is caused partly by the lack of a protein that has not previously been associated with diabetes.
Association canadienne du diabète, Instituts de recherche en santé du Canada

Contact: William Raillant-Clark
rw.raillantclark@gmail.com
514-343-7593
University of Montreal

Showing releases 426-450 out of 718.

<< < 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 > >>